Dr. Monika Bahl is a medical professional trained in business management, project planning and management with over 25 years’ experience in clinical research industry. Significant experience of managing projects in varied therapeutic indications spanning a broad spectrum of responsibilities from clinical development program, grant writing, project planning, regulatory, operational & medical monitoring, medical writing and overall project management for clinical trials, academic projects and research initiatives of national interest. Worked at Ranbaxy, Panacea Biotec, Dabur Research, Quintiles, DNDi and has been engaged in strategic planning and operational execution of research activities and clinical trial management, resource utilization and forecast resource requirement to facilitate effective resource planning throughout the life of the product development, define project workloads and assignment and develop and oversee maintenance of internal databases and project plans. Senior advisor for CROs and Pharma companies, technical experts with ICMR, BIRAC, SMEs and academic institutes, IEC member and visiting faculty to research organizations and academic institutes. As Chief- Clinical Portfolio Management with Clinical Development Services Agency-THSTI leading the public health research portfolio in collaboration. with DBT, ICMR, academicians, SMEs, researchers and funding agencies, responsible for development of overall strategy, contribute to developing the clinical trials/studies portfolio including grant /medical writing, clinical operations and safety monitoring.